FIELD: medicine; pharmaceuticals.
SUBSTANCE: presented group of inventions refers to pharmaceutical industry, namely to a composition for intravaginal introduction for treating disorders with estrogen deficiency. Disclosed is a capsular pharmaceutical composition containing: a gelatine capsule and a liquid pharmaceutical composition containing: from 1 microgram to 25 micrograms of soluble oestradiol and a dissolving agent, wherein the dissolving agent contains at least one of C6-C12 fatty acids or a glycol, monoglyceride, diglyceride or triglyceride ester thereof, where the pharmaceutical composition does not contain a hydrophilic gel-forming bioadhesive agent, and where the liquid pharmaceutical formulation is encapsulated in a gelatine capsule. Disclosed is a capsule pharmaceutical composition for intravaginal administration for the treatment of disorders with estrogen deficiency, containing: 1 microgram to 25 micrograms of oestradiol; caprylic/capric acid triglyceride; non-ionic surfactant, which is PEG-6 stearate and ethylene glycol palmitostearate; wherein the pharmaceutical formulation is encapsulated in a soft gelatine capsule. Disclosed is a method of treating disorders in the absence of estrogen, the method involves administering a capsule pharmaceutical composition for intravaginal administration to a woman in need thereof.
EFFECT: use of the above formulations is effective for treating estrogen deficiency disorders, promotes localized action of oestradiol without noticeable increase in the system effects of oestradiol.
18 cl, 2 dwg, 4 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS AND METHODS BASED ON OESTRADIOL FOR INTRAVAGINAL INTRODUCTION | 2014 |
|
RU2713888C2 |
PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
HORMONE-CONTAINING EMULSION | 2013 |
|
RU2678319C2 |
MICROEMULSION COMPOSITIONS INCLUDING SUBSTANCE P ANTAGONISTS | 2005 |
|
RU2397759C2 |
USING 5-AMINOLEVULINIC ACID AND DERIVATIVES THEREOF IN SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSTICS | 2008 |
|
RU2521228C2 |
LIPID COMPOSITIONS OF RACECADOTRIL | 2013 |
|
RU2632441C2 |
SOLID COMPOSITIONS CONTAINING 5-AMINOLEVULINIC ACID | 2010 |
|
RU2527328C2 |
ABT-263 CAPSULE | 2010 |
|
RU2550956C2 |
RACECADOTRIL LIPID COMPOSITIONS | 2014 |
|
RU2662069C2 |
PHARMACEUTICAL COMPOSITIONS COMPRISING CAMPTOTHECIN DERIVATIVE | 2012 |
|
RU2620331C2 |
Authors
Dates
2020-12-31—Published
2013-06-18—Filed